Amicus Therapeutics (FOLD): Volume dana dhuwit perusahaan

FOLD (Amicus Therapeutics, Inc.) - tandha merek perusahaan

Amicus Therapeutics' transition to a profitable commercial model is evident on the chart: the cash balance history demonstrates financial stability, where the value of 0.29 reflects this status. Growth is driven by patents for the therapy of rare metabolic pathologies. AI molecule screening and line automation enhance efficiency, although clinical trials remain the domain of scientists.

Dhuwit awis perusahaan: Amicus Therapeutics Inc (FOLD) kanggo 04.07.2022 - 09.05.2026

Rincian metrik lan analitis perusahaan Amicus Pharma (FOLD)

- nilai saham lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:FOLD amicusrx.com
Produk merek Amicus Therapeutics Inc

This indicator aggregates the volume of liquid assets and equivalents, allowing for an assessment of the business's ability to fund expansion or cover operational gaps without incurring external debt. For Amicus Therapeutics (FOLD), with its high margins in the orphan drug segment, the cash level confirms financial stability and the capacity to sustain the development of unique medications without the risk of capital degradation.

Pesaing utama

Dana dhuwit perusahaan ascendispharma.com (ASND)|Dhuwit awis perusahaan madrigalpharma.com MDGL|Volume dana dhuwit perusahaan CORT (Corcept Therapeutics Inc.)|Sisa dhuwit perusahaan RYTM|AKRO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Metsera Inc|MoonLake Immunotherapeutics AG (MLTX) - Dana dhuwit perusahaan|CRNX - Aset likuid perusahaan|NAMS (newamsterdampharma.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Soleno Therapeutics Inc SLNO|Dhuwit awis perusahaan ETNB (89bio Corp)|Aset likuid perusahaan Agios Pharmaceuticals|Structure Pharma - Dhuwit awis perusahaan|MDXG: Dhuwit awis lan setara dhuwit awis perusahaan|RZLT: Dhuwit awis perusahaan|LXRX (Lexicon Pharma) - Dhuwit awis lan setara dhuwit awis perusahaan|MBX: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Altimmune, Inc. (ALT)|Dhuwit awis perusahaan AARD|Dana dhuwit perusahaan SGMT|Volume dana dhuwit perusahaan BIOA|Aset likuid perusahaan Biomea Fusion|Dana dhuwit perusahaan Quince Therapeutics QNCX|Volume dana dhuwit perusahaan Fractyl Health, Inc GUTS|VTVT: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan Agape ATP|PLUR (Pluri) - Dhuwit awis perusahaan|SYBX - Aset likuid perusahaan|Dana dhuwit perusahaan Lipocine Corp|Volume dana dhuwit perusahaan matinasbiopharma.com|Dana dhuwit perusahaan Spruce Biosciences, Inc. (SPRB)|Gunggung dana dhuwit perusahaan GLTO|Carmell Corporation - Dhuwit awis perusahaan|LUMO - Dhuwit awis perusahaan|ONVO - Dana dhuwit perusahaan|Sisa dhuwit perusahaan RDUS (Radius Health)